HLS Therapeutics Inc.
TSX:HLS
C$ 3.94
C$0.00 (0.00%)
C$ 3.94
C$0.00 (0.00%)
End-of-day quote: 05/17/2024

HLS - HLS Therapeutics Stock Prediction 2025 - 2030

6 years of reliable HLS Therapeutics stock forecast. The Wall Street analysts predict Outperform for HLS. See at a glance whether TSX:HLS will rise in the future.

C$0.00
Forecast 2023
C$4.56
Forecast 2025
C$7.13
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
C$0.00
Forecast 2025
C$4.56
Forecast 2030
C$7.13
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.09
Price-to-book Ratio
1.42
Market Cap
0.13B
TEV
0.22 B
Dividend
C$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
C$6.07
Country

HLS Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

HLS Therapeutics Stock Forecast 2023

C$2.92

In the last five quarters, HLS Therapeutics’s Price Target has fallen from C$27.28 to C$6.07 - a -77.75% decrease. Three analysts predict that HLS Therapeutics’s share price will fall in the coming year, reaching C$2.92. This would represent a decrease of -51.89%.

-25.89%
-25.89
Last update: 05/20/2024

Highest Price Target C$6.95

Average Price Target C$2.92

Lowest Price Target C$2.74

HLS Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One HLS Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of C$4.20. An increase of 6.58% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of C$4.23. An increase of 7.4% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of C$4.26. An increase of 8.23% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of C$4.30. An increase of 9.05% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of C$4.33. An increase of 9.88% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of C$4.36. An increase of 10.7% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of C$4.39. An increase of 11.53% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of C$4.43. An increase of 12.35% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of C$4.46. An increase of 13.18% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of C$4.49. An increase of 14% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of C$4.52. An increase of 14.83% compared to today's share price.

Stock Prediction for the Price of One HLS Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of C$4.56. An increase of 15.65% compared to today's share price.

HLS Therapeutics Stock Predictions 2030

HLS Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of C$6.57. An increase of 66.71% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of C$6.62. An increase of 68% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of C$6.67. An increase of 69.29% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of C$6.72. An increase of 70.58% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of C$6.77. An increase of 71.87% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of C$6.82. An increase of 73.16% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of C$6.87. An increase of 74.45% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of C$6.92. An increase of 75.74% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of C$6.98. An increase of 77.03% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of C$7.03. An increase of 78.32% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of C$7.08. An increase of 79.61% compared to the previous month's estimate.

HLS Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of C$7.13. An increase of 80.9% compared to the previous month's estimate.

P/E
0.00
Beta
1.09
Price-to-book Ratio
1.42
Market Cap
0.13B
TEV
0.22 B
Dividend
C$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
C$6.07
Country

HLS Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching HLS Therapeutics Inc.?

The following analysts have recently covered HLS Therapeutics:

Bloom Burton & Co.
Raymond James Ltd.
Stifel Canada
Clarus Securities Inc.
Canaccord Genuity
(This information refers to the last 90 days.)

Who are the sell-side analysts watching HLS Therapeutics Inc.?

The following sell-side analysts have recently covered HLS Therapeutics:

Martin, David C.
Sarugaser, Rahul
Keywood, Justin
Ulybyshev, George
Armstrong-Whitworth, Tania Rae
(This information refers to the last 90 days.)